Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

AML
December 8, 2019/Cancer/Research

Studies’ Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials

Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes

650×450-Acute lymphoblastic-leukemia2
December 7, 2019/Cancer/Research

Pediatric-inspired Post-remission Chemotherapy Superior to Stem Cell Transplantation for Young Adults with ALL

Study results from ASH 2019 shed light on treatment

DeBernardo, MD
December 5, 2019/Cancer

Factors Associated with Non-Completion of IP/IV Chemotherapy in Women with Epithelial Ovarian Cancer

Non-home discharge and higher ECOG status associated with IP/IV chemotherapy non-completion

19-NEU-5569-glioblastoma-perfusion-image-650×450
December 2, 2019/Cancer

Using Machine Learning to Distinguish Brain Tumor Progression From Pseudoprogression on Routine MRI

Algorithm reveals many features not appreciated by the unaided eye

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-OBG-1457_CQD-650x450_Hero_927460490
November 25, 2019/Cancer

Depression, Obesity and Sleep in Endometrial Cancer Survivors

Greater weight means less sleep, lower quality of life

19-NEU-6043-brain-metastases-650×450
November 22, 2019/Cancer

Brain Metastases: Standard of Care and Novel Therapies (Podcast)

A neurosurgeon and a neuro-oncologist recap recent and emerging advances

Emre Gorgun, MD
November 21, 2019/Cancer

Cleveland Clinic is First to Successfully Use Endoscopic-Assist Device for Endoluminal Resection of Complex Colorectal Polyps

Instrument aids natural orifice endoluminal surgery

19-CCC-6024-top10Innov-2019-9_650x450
November 15, 2019/Cancer

No. 9 Medical Innovation for 2020: PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

Reducing risk of recurrence 70%

This color fundus photo of the clinical presentation of a left eye affected by radiation retinopathy shows multiple retinal exudates (yellow material) surrounding the irradiated tumor. Copyright image used with permission from Elsevir.
November 15, 2019/Cancer

Creating a First-Ever Animal Model of Brachytherapy-Induced Radiation Retinopathy

First step toward testing therapeutics

Zahler, DO
November 11, 2019/Cancer

Study Sheds New Light on the Role of Prohibitin in Wilms’ Tumor

Urine prohibitin identified as a prognostic biomarker in Wilms’ tumor

BackPage 60 of 112Next

Advertisement

Ad